메뉴 건너뛰기




Volumn 343, Issue 9, 2010, Pages 489-499

Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials

Author keywords

Bioavailability; Cancer; Clinical trials; Curcumin; Inflammation

Indexed keywords

4 METHOXYAMPHETAMINE; APOPTOSIS INDUCING FACTOR; BCM 95; BETA CATENIN; BIOCURCUMAX; CASPASE; CASPASE 3; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; CURCUMIN; CYCLIN D1; CYCLOOXYGENASE 2; CYTOCHROME C; DIPHENYLDIFLUOROKETONE; ENDONUCLEASE G; GELATINASE B; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 77956863976     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200900319     Document Type: Review
Times cited : (476)

References (100)
  • 2
    • 34548227773 scopus 로고    scopus 로고
    • S. Singh, Cell 2007, 130, 765-768.
    • (2007) Cell , vol.130 , pp. 765-768
    • Singh, S.1
  • 21
    • 0035890085 scopus 로고    scopus 로고
    • X. Wang, Genes Dev. 2001, 15, 2922-2933.
    • (2001) Genes Dev. , vol.15 , pp. 2922-2933
    • Wang, X.1
  • 46
  • 68


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.